TRPC3, but not TRPC1, as a good therapeutic target for standalone or complementary treatment of DMD.
Creisméas A, Gazaille C, Bourdon A, Lallemand MA, François V, Allais M, Ledevin M, Larcher T, Toumaniantz G, Lafoux A, Huchet C, Anegon I, Adjali O, Le Guiner C, Fraysse B.
Creisméas A, et al. Among authors: gazaille c.
J Transl Med. 2021 Dec 20;19(1):519. doi: 10.1186/s12967-021-03191-9.
J Transl Med. 2021.
PMID: 34930315
Free PMC article.